YGF-22050-63391 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-23
Registered in v-safe
2020-12-23
Dose 1 — Pfizer-BioNTech
2020-12-25
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-26
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-28
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-29
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-30
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-06
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-12
Dose 2 — Pfizer-BioNTech
2021-01-15
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-01-15
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-16
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Chills, Headache, Joint pains · Be unable to do your normal daily activities

Adult check-in
2021-01-16
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-17
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-18
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-01-19
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-01-26
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-02
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-09
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-12
Call 1 — Left Voicemail
2021-02-16
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-23
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-13
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-13
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-12
Survey response — 12 months, dose 2
MedDRA: Respiratory syncytial virus infection, Respiratory tract infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: RSV + Respiratory infection

MedDRA releases: 2024-11 · check-in free text available
2022-01-12
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-01-14
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-23	Pfizer-BioNTech
2	2021-01-12	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-01-15	Unsuccessful
2021-01-16	Unsuccessful
2022-01-12	Unsuccessful

Free text

Release 10 — 12 months, dose 2

2022-01-12

Symptoms: RSV + Respiratory infection

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Respiratory syncytial virus infection	·	·	✓
SD	Respiratory tract infection	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release